Literature DB >> 8836173

Transcriptional repression by Rev-erbA alpha is dependent on the signature motif and helix 5 in the ligand binding domain: silencing does not involve an interaction with N-CoR.

M Downes1, L J Burke, G E Muscat.   

Abstract

Rev-erbA alpha is an orphan nuclear receptor that functions as a dominant transcriptional repressor. Tissue culture and in situ hybridisation studies indicated that Rev-erbA alpha plays an important role in mammalian differentiation and development. Previous studies have localised the silencing domain of Rev-erbA alpha to the D/E region of the orphan receptor. This study utilised the GAL4 hybrid system to demonstrate that efficient repression is mediated by 34 amino acids (aa) between aa 455 and 488 in the E region of the receptor. This domain contains the ligand binding domain (LBD)-signature motif [(F/W)AKxxxxFxxLxxxDQxxLL] and a region that, according to the recently published crystal structures of steroid receptors, would be predicted to form helix 5 of the canonical LBD structure. Fine deletions and site-specific mutagenesis indicated that both the LBD signature motif and helix 5 were necessary for efficient silencing. Utilising mammalian two hybrid technology, we have also demonstrated that Rev-erbA alpha does not associate with the interaction domain (aa 2218-2451) of the nuclear receptor corepressor, N-CoR, that is known to interact with the thyroid hormone and retinoic acid receptors. This suggested that transcriptional repression by Rev-erbA alpha is not mediated through an interaction with N-CoR. In conclusion, we have identified and characterised the minimal domain of Rev-erbA alpha, that mediates transcriptional repression by this orphan receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836173      PMCID: PMC146124          DOI: 10.1093/nar/24.18.3490

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  42 in total

1.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription.

Authors:  G J Kato; J Barrett; M Villa-Garcia; C V Dang
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Thyroid hormone receptor dimerization function maps to a conserved subregion of the ligand binding domain.

Authors:  J W Lee; T Gulick; D D Moore
Journal:  Mol Endocrinol       Date:  1992-11

3.  Thyroid hormone receptor mutations that interfere with transcriptional activation also interfere with receptor interaction with a nuclear protein.

Authors:  A L O'Donnell; E D Rosen; D S Darling; R J Koenig
Journal:  Mol Endocrinol       Date:  1991-01

4.  Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site.

Authors:  A Baniahmad; C Steiner; A C Köhne; R Renkawitz
Journal:  Cell       Date:  1990-05-04       Impact factor: 41.582

5.  An amino-terminal fragment of GAL4 binds DNA as a dimer.

Authors:  M Carey; H Kakidani; J Leatherwood; F Mostashari; M Ptashne
Journal:  J Mol Biol       Date:  1989-10-05       Impact factor: 5.469

6.  The orphan receptor Rev-ErbA alpha activates transcription via a novel response element.

Authors:  H P Harding; M A Lazar
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

7.  Induction of Rev-ErbA alpha, an orphan receptor encoded on the opposite strand of the alpha-thyroid hormone receptor gene, during adipocyte differentiation.

Authors:  A Chawla; M A Lazar
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

8.  Characterization of the thyroid hormone response element in the skeletal alpha-actin gene: negative regulation of T3 receptor binding by the retinoid X receptor.

Authors:  G E Muscat; R Griggs; M Downes; J Emery
Journal:  Cell Growth Differ       Date:  1993-04

9.  A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor.

Authors:  A Baniahmad; A C Köhne; R Renkawitz
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

10.  Evolution of the nuclear receptor gene superfamily.

Authors:  V Laudet; C Hänni; J Coll; F Catzeflis; D Stéhelin
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  8 in total

1.  Novel receptor interaction and repression domains in the orphan receptor SHP.

Authors:  W Seol; M Chung; D D Moore
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

2.  Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: physical association is dependent on the E region of the orphan receptors.

Authors:  M Downes; L J Burke; P J Bailey; G E Muscat
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

3.  The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70.

Authors:  G E Muscat; L J Burke; M Downes
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

4.  UNC-55, an orphan nuclear hormone receptor, orchestrates synaptic specificity among two classes of motor neurons in Caenorhabditis elegans.

Authors:  H M Zhou; W W Walthall
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

5.  Retinoid-related Orphan Receptors (RORs): Roles in Cellular Differentiation and Development.

Authors:  Anton M Jetten; Joung Hyuck Joo
Journal:  Adv Dev Biol       Date:  2006

6.  Retinoic Acid-Related Orphan Receptors (RORs): Regulatory Functions in Immunity, Development, Circadian Rhythm, and Metabolism.

Authors:  Donald N Cook; Hong Soon Kang; Anton M Jetten
Journal:  Nucl Receptor Res       Date:  2015-12-16

Review 7.  Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism.

Authors:  Anton M Jetten
Journal:  Nucl Recept Signal       Date:  2009-04-03

8.  The structural basis of gas-responsive transcription by the human nuclear hormone receptor REV-ERBbeta.

Authors:  Keith I Pardee; Xiaohui Xu; Jeff Reinking; Anja Schuetz; Aiping Dong; Suya Liu; Rongguang Zhang; Jens Tiefenbach; Gilles Lajoie; Alexander N Plotnikov; Alexey Botchkarev; Henry M Krause; Aled Edwards
Journal:  PLoS Biol       Date:  2009-02-24       Impact factor: 8.029

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.